Pharmafile Logo
Pharmafocus logo
Advanced Search

Capturing the Brazilian pharma opportunity

May 16, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brazil, McKinsey, market access, middle class, pharma

 Many multinationals are hungry to sell their goods and services to the emerging markets’ growing middle class, comprising nearly two …

Feature
Zytiga image

Price cut sways NICE on Zytiga

May 16, 2012
Sales and Marketing Jevtana, NICE, Zytiga, prostate cancer

NICE is recommending Janssen’s prostate cancer pill Zytiga, reversing its previous stance.  In its final guidance, the watchdog is recommending …

News

Open Health appoints new digital designer

May 16, 2012
Business Services, Medical Communications, Sales and Marketing Open Health

Leo Jacobs has been appointed by Open Health as a digital designer to sit within its OPEN Source team. The …

Appointment

Merck KGaA sets out savings target as staff threaten to strike

May 15, 2012
Research and Development, Sales and Marketing Merck KGaA, R&D, Serono, cuts

Merck KGaA has outlined its plan to make €300 million in savings from its Serono drugs unit, with over half …

News

CoreLab Partners collaborates at industry conferences worldwide

May 15, 2012
Research and Development

Princeton, NJ May 15, 2012 – CoreLab Partners, Inc, a leading independent core lab providing centralized cardiac safety services and …

News
Press release

Genentech taken to task over Avastin production

May 15, 2012
Manufacturing and Production Genentech, Phil Taylor, avastin, manufacturing

FDA inspections of a manufacturing facility for Roche/Genentech’s cancer drug Avastin (bevacizumab) uncovered a number of deficiencies which could increase …

News
abpi image

ABPI launches new NHS partnership guide

May 15, 2012
Medical Communications, Sales and Marketing ABPI, COPD, NHS, code

The Association of the British Pharmaceutical Industry has launched a new guide to explain how pharma and the NHS can …

News
GSK picture

GlaxoSmithKline to acquire Cellzome for £61 million

May 15, 2012
Research and Development, Sales and Marketing Cellzome, Domantis, GSK, R&D

GlaxoSmithKline will expand its platform technology capability with the acquisition of a chemical proteomics company.  GSK will acquire those shares …

News

Synthetic Biologics appoints Carol Reed

May 15, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Carol Reed, Synthetic

Synthetic Biologics has appointed Carol Reed as senior vice president of Clinical & Regulatory Affairs. In this position Reed will …

Appointment
Gilenya image

Gilenya to stay on US market – but with new safety warnings

May 15, 2012
Sales and Marketing EMA, FDA, Novartis, PML, gilenya

The FDA says that Novartis’ multiple sclerosis pill Gilenya should stay on the market, but has added new safety warnings …

News
yervoy image

Scottish watchdog rejects Yervoy

May 14, 2012
Sales and Marketing BMS, Cancer, NICE, SMC, Yervoy, melanoma

The Scottish Medicines Consortium is not recommending Bristol-Myers Squibb’s melanoma treatment Yervoy.  The SMC said that Yervoy (ipilimumab), which has …

News

New Quad HIV pill on track for FDA approval

May 14, 2012
Research and Development, Sales and Marketing BMS, Compera, FDA, Gilead, HIV, The Quad

Gilead Sciences’ four-in-one HIV pill has been given the thumbs up by an FDA advisory group.  The US regulator is …

News
FDA picture

Obesity drugs vie for approval as FDA panel backs lorcaserin

May 14, 2012
Research and Development, Sales and Marketing Arena, Eisai, FDA, Qnexa, lorcaserin, obesity

An FDA panel has recommended Arena’s obesity drug lorcaserin, setting up a showdown with Vivus’ Qnexa. Qnexa was recommended by an FDA panel …

News

BASF buys Equateq to tap into growing health ingredient business

May 11, 2012
Manufacturing and Production BASF, Equateq, Phil Taylor, omega-3

BASF has said it intends to buy Equateq, a UK-based specialist in lipid ingredients that represent a ‘global growing market’, …

News

Outsourcing on the up, but contract manufacturing still under pressure

May 11, 2012
Manufacturing and Production CMO, Jim Millar, PharmaSource, Phil Taylor, outsourcing

The pharmaceutical contract services sector experienced something for a recovery in 2011 after a lean couple of years, although the …

News

Code of Practice update to reflect legal changes

May 11, 2012
Medical Communications ABPI, Code of Practice, MHRA, PMCPA, patient organisations

The UK pharma industry’s Code of Practice is set to be updated to bring it into line with changes in …

News
NICE image

NICE changes its mind on Botox

May 11, 2012
Sales and Marketing Allergan, Botox, NHS, NICE

NICE is now recommending Allergan’s Botox for chronic migraines, reversing its previous decision.  The watchdog said in final draft guidance …

News

Gamification and online communities – what can pharma do?

May 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Facebook, Gamification, Syrum, digital marketing

Gamification is the new buzzword in digital marketing and has the potential to engage consumers more than traditional strategies. This new …

Feature
neil_weir_abpi-12

ABPI appoints new Innovation Board Chair

May 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Neil Weir, Whitehead

The senior vice president of discovery at UCB, Neil Weir, has been appointed as the next Chair of the ABPI …

Appointment
dr_jeremy_levin_web_only

Teva appoints new president and chief executive

May 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Jeremy Levin, Teva

Ex-BMS head Dr Jeremy Levin has been appointed president and chief executive of Teva.  Prior to joining Teva, Levin, who …

Appointment
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026